￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Aficamten-MYQORZO is a medicine that treats what

2026-02-01 22:25:32

Check Details
Manufacturer and brand information of mirikizumab

2026-02-01 22:25:32

Check Details
What is the best time to take Selumetinib/Coselyu?

2026-02-01 22:25:32

Check Details
Can lorlatinib/lorlatinib (Borina) be continued for a long time?

2026-02-01 22:25:32

Check Details
Is there a domestic version of Cabozantinib?

2026-02-01 22:25:32

Check Details
The specific situation of the targeted drug Pralsetinib entering medical insurance in 2026

2026-02-01 22:25:32

Check Details
Capmatinib/Touradida belongs to which generation of targeted drugs

2026-02-01 22:25:32

Check Details
Aficamten-MYQORZO manual Chinese introduction

2026-02-01 22:25:32

Check Details
The specific efficacy and role of larotrectinib/vitaikai in the treatment of cancer

2026-02-01 22:25:32

Check Details
STOMP trial analysis reveals the immunomodulatory effects of selinezo/silvio in RRMM

2026-02-01 22:25:32

Check Details
Detailed explanation of the efficacy and role of Vigabatrin/vigabatrin in treating epilepsy

2026-02-01 22:25:32

Check Details
How Mobocertinib inhibits EGFR exon 20 to treat disease

2026-02-01 22:25:32

Check Details
Category
相关知识